E-LIB Suche - Ergebnisse für: Dacco', V.

1

P198 Phenotypic and genotypic characterization of Mycobacte..:

Liporace, M.F. ; Teri, A. ; Girelli, D....
Journal of Cystic Fibrosis. 23 (2024) - p. S130 , 2024

Link: https://doi.org/10.1016/..

2

Reported Adverse Events in a Multicenter Cohort of Patients..:

Terlizzi, V. ; Fevola, C. ; Presti, S....
The Journal of Pediatrics. , 2024

Link: https://doi.org/10.1016/..

3

P063 ELX/TEZ/IVA has beneficial effects on clinical outcome..:

Solé, A. ; Ratjen, F. ; Schwarz, C....
Journal of Cystic Fibrosis. 23 (2024) - p. S85-S86 , 2024

Link: https://doi.org/10.1016/..

4

P109 Safety of elexacaftor/tezacaftor/ivacaftor in patients..:

Terlizzi, V. ; Fevola, C. ; Presti, S....
Journal of Cystic Fibrosis. 23 (2024) - p. S118-S119 , 2024

Link: https://doi.org/10.1016/..

5

P169 Lung clearance index as an alternative respiratory out..:

Alicandro, G. ; Nazzari, E. ; Zazzeron, L....
Journal of Cystic Fibrosis. 23 (2024) - p. S107 , 2024

Link: https://doi.org/10.1016/..

6

P177 Impact of elexacafor/ivacaftor/tezacaftor therapy on A..:

Lanfranchi, C. ; Alicandro, G. ; Claut, L....
Journal of Cystic Fibrosis. 23 (2024) - p. S110 , 2024

Link: https://doi.org/10.1016/..

7

719 Elexacaftor-tezacaftor-ivacaftor therapy improves early..:

Zazzeron, L. ; Alicandro, G. ; Nazzari, E....
Journal of Cystic Fibrosis. 22 (2023) - p. S397 , 2023

Link: https://doi.org/10.1016/..

8

Risk of CFTR-related disorders and cystic fibrosis in an It..:

Fevola, C. ; Dolce, D. ; Tosco, A....
European Journal of Pediatrics. 183 (2023) 2 - p. 929-938 , 2023

Link: https://doi.org/10.1007/..

9

Effects of insulin therapy optimization with sensor augment..:

Grancini, V. ; Alicandro, G. ; Porcaro, L. L....
Frontiers in Endocrinology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

10

P160 Effects of elexacaftor/tezacaftor/ivacaftor triple com..:

Zazzeron, L. ; Gramegna, A. ; Grancini, V....
Journal of Cystic Fibrosis. 22 (2023) - p. S114 , 2023

Link: https://doi.org/10.1016/..

11

Humoral and cell-mediated immune responses to BNT162b2 vacc..:

Alicandro, G. ; Orena, B.S. ; Rosazza, C....
Vaccine. 41 (2023) 28 - p. 4114-4120 , 2023

Link: https://doi.org/10.1016/..

12

P155 The impact of elexacaftor/tezacaftor/ivacaftor (ETI) t..:

Cariani, L. ; Alicandro, G. ; Teri, A....
Journal of Cystic Fibrosis. 22 (2023) - p. S112 , 2023

Link: https://doi.org/10.1016/..

13

P154 Cluster analysis explains heterogeneity in treatment r..:

Gramegna, A. ; Alicandro, G. ; Retucci, M....
Journal of Cystic Fibrosis. 22 (2023) - p. S112 , 2023

Link: https://doi.org/10.1016/..

14

718 Lung clearance index decreases in patients who do not a..:

Nazzari, E. ; Alicandro, G. ; Zazzeron, L....
Journal of Cystic Fibrosis. 22 (2023) - p. S396-S397 , 2023

Link: https://doi.org/10.1016/..

15

P153 An Italian centre experience with elexacaftor/tezacaft..:

Rosazza, C. ; Alicandro, G. ; Zazzeron, L....
Journal of Cystic Fibrosis. 22 (2023) - p. S112 , 2023

Link: https://doi.org/10.1016/..